Early Access — free while we kick the tires
EdgarHawk

C Taylor Pickett

CHIEF EXECUTIVE OFFICER

Director Officer

Latest: Director selling · May 2026

2 filings analyzed · 2 companies · Latest 2026-06-02

Companies

Company Buys Sells Direction
COPT DEFENSE PROPERTIES CDP 0 1 Net selling
OMEGA HEALTHCARE INVESTORS INC OHI 1 0 Net buying

Activity

June 2026
high
Sell
31,798 shares
$1,025,581
Significance 6/10

Director C Taylor Pickett sold 31.8K shares (67.7% stake reduction) at $32.25; stock now $31.86, near 52-week highs.

C Taylor Pickett, a Director of COPT Defense Properties, sold 31,798 shares at $32.25 on 2026-05-29, reducing his holdings from 46,986 to 15,188 shares—a 67.7% reduction in position size. The sale occurred near the 52-week high of $33.33 (current price $31.86 is -4.4% from peak), and the company shows solid fundamentals with net income of $40,139,000 against revenue of $200,637,000 on modest annual growth of +1.4% and a P/E of 22.12. Across his open-market history, Pickett's prior buy showed an average 90-day return of -0.5% with a 0% win rate, providing limited directional insight into his timing patterns. The substantial reduction in his ownership stake warrants investor attention regarding the Director's retained conviction in the company, though the execution near year-to-date highs and the company's stable operational performance provide context for interpreting the reduction.

November 2025
Buy
20,000 shares
$862,856
Significance 6/10

OHI CEO Pickett C Taylor purchases 20,000 shares for $862.9K at $43.14, establishing new position

CEO Pickett C Taylor acquired 20,000 shares at $43.14 on 2025-11-05, establishing an initial position in OHI with a $862.9K purchase. The transaction executed near the 52-week high of $43.34, representing a material open-market commitment by the company's top executive. Against the company's strong fundamentals—revenue of $311.6M, net income of $179.7M, and annual revenue growth of +10.7%—this CEO purchase from a zero-position baseline signals a new alignment of interests. The stock's 30-day performance of +3.8% and 90-day performance of +6.7% provide context for the timing, though the absolute dollar commitment and executive rank merit investor tracking regardless of near-term price dynamics.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access